针对线粒体的Cu2-xSe-TPP具有双重酶活性,通过调节氧化应激来缓解阿尔茨海默病
Liqiang Wang1, Xiaoyu Yuan2, Qianyu Cai2
1Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen 518110, China; College of Chemistry and Materials Science of Jinan University, Guangzhou 510632, China.
Colloids and surfaces. B, Biointerfaces
|October 4, 2024
概括
这项研究引入了针对阿尔茨海默病 (AD) 中线粒体功能障碍和神经炎症的新型纳米酶. 这些纳米酶有效降低氧化应激和炎症,为AD提供了有前途的新治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
背景情况:
- 微质中的线粒体功能障碍是阿尔茨海默病 (AD) 发病的一个关键因素.
- 由线粒体功能障碍驱动的氧化应激和神经炎症有助于AD中神经元死亡.
研究的目的:
- 开发一种"双制动"策略,同时解决线粒体功能障碍和AD治疗中微质中的神经炎症.
- 设计和评估针对微质中的线粒体的新型纳米酶.
主要方法:
- 合成 (3-carboxypropyl) triphenyl-phosphonium bromide (TPP) 修饰的 Cu2-xSe 纳米酶 (Cu2-xSe-TPP NP) 具有双重类似酶的活性 (超氧化物脱酶模拟和酶模拟).
- 使用AD模型小鼠进行体内研究,以评估Cu2-xSe-TPPNP对氧化应激,神经炎症和认知缺陷的影响.
主要成果:
- Cu2-xSe-TPPNP有效地清除了反应性氧物种 (ROS) 并减轻了微质中的线粒体氧化应激.
- 纳米酶促进了AD模型小鼠海马中的神经保护.
- Cu2-xSe-TPP NPs将微质两极分化从促炎M1转移到抗炎M2表型,增强了Aβ细胞化,并改善了认知功能.
结论:
- 开发的Cu2-xSe-TPPNP提供了一种协同方法,以阻止AD中的线粒体功能障碍和神经炎症.
- 这种预防线粒体损伤和重塑炎症微环境的策略为阿尔茨海默病提供了一个新的治疗前景.
相关概念视频
01:46Electron Transport Chain: Complex I and II
12.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170